Conjugation of universal, functionally de-targeted OneAAVTM capsid provides on-demand specificity and scalabilityto address ...

MPR spoke with Dr Daniela Carvalho, an investigator in the CHORD trial, the results form which formed the basis for the approval of Otarmeni.

Sleep Apnea Solution author Dylan Petkus, MD, has developed a non-device, behavior-based alternative approach to sleep apnea.

Treating patients who have spent years—sometimes decades—avoiding dental care because of fear, disability, trauma or painful ...

Learning a new language doesn’t have to be all textbooks and drills — music and karaoke can make it fun, memorable, and culturally rich. Singing along to songs helps improve pronunciation, expand ...

The FDA has granted accelerated approval to Otarmeni™ (lunsotogene parvec-cwha), the first gene therapy for pediatric and adult patients with OTOF-related sensorineural hearing loss.

Learning a new language is exciting, but without a clear plan, progress can feel slow and frustrating. A personalized, structured approach—balancing vocabulary, grammar, and real-life practice—can ...

The global rise in life expectancy has brought with it a dramatic increase in age-related health conditions, particularly those affecting sensory and ...